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OBJECTIVES: Provider continuity is defined as seeing the samehealth care provider
over time. Previous studies indicated that high provider continuity improves
health care outcomes and the efficiency of health care delivery. The impact of
provider continuity in sickle cell disease (SCD) care, however, is unknown. This
study examined the association between provider continuity and the risk of SCD-
related hospitalization and re-hospitalization within 30 days of discharge.
METHODS: A retrospective cohort study was conducted using Florida Medicaid
claims data from 2001-2005. Patients with claims containing SCD-related ICD-9
codes (282.41-282.42, 282.6- 282.64, 282.68-282.69) were selected. To be eligible,
individuals had to be aged65 years, continuously enrolled in Medicaid, and have
made2 ambulatory visits.Modifiedmodified continuity index (MMCI) scoreswere
calculated to quantify provider continuity. Cox proportional hazard modeling was
used to examine the relationship between MMCI and hospitalization and 30-day
re-hospitalization controlling for basic demographics, prior utilization, SCD treat-
ments and complications. RESULTS: A total of 2422 patients with mean age of 10.2
(SD11.9) and 47.2% male were included. Average MMCI score was 0.60 (SD0.28),
53.47% had 1 SCD-related hospitalization; of those, 18.8% were re-hospitalized
within 30 days. After controlling for patient-level factors, patients with higher
provider continuity were less likely to be hospitalized (HR0.53, 95% CI: 0.44-0.65),
but MMCI was not significantly associated with 30-day risk of re-hospitalization
(HR0.89, 95% CI0.55-1.43). CONCLUSIONS:Higher provider continuity was asso-
ciated with a lower risk of SCD-related hospitalization in the Florida Medicaid SCD
population, but did not affect the rate of 30-day re-hospitalization. Policies that
improve andmaintain continuity between SCD patients and a single provider may
lead to lower hospitalization rates and possibly lower health care costs.
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OBJECTIVES: Thrombocytopenia, or low blood platelet count, is associated with
disease progression and treatment for several chronic conditions, including liver
disease, cancer, and HIV. Yet, little information describing the impact of thrombo-
cytopenia on patients is available. This study compared indicators of health and
functional status among individuals with and without thrombocytopenia.
METHODS: 1999-2008 National Health and Nutrition Examination Survey
(NHANES) data were used to identify individuals aged 20 years with normal and
low platelets, using a threshold of 150x109/L. Indicators of health and/or functional
status included self-reported general health [1-5 scale, 1excellent], number of
health care visits and overnight hospital stays, days physical health was not good,
inactive days due to physical health, and work limitations. Weighted means and
frequencies were summarized and compared using paired t-tests and chi-squared
tests, respectively. RESULTS: 22,959/25,772 participants aged 20 years had infor-
mation on platelets. Of these, 526 (1.9%) had low platelets at the time of examina-
tion. Individuals with thrombocytopenia were older (51.7 vs 37.2 years) and more
likely to be male (67.7% vs 48.6%), infected with hepatitis C (7.4% vs 1.4%), and ever
diagnosed with cancer (14.2% vs 8.0%) or a liver condition (12.3% vs 3.1%), p.05 for
all. Fewer participantswith thrombocytopenia reported excellent health compared
to those with normal platelets (12.5% vs 16.5%, p.0001). Participants with throm-
bocytopenia reported more health care provider visits (2.35 vs 2.02, p.0001) and
were more likely to report an overnight hospital stay (0.19% vs 0.11%, p.001).
Participants with thrombocytopenia hadmore inactive days due to physical health
and were more likely to face work limitations (p.01 for all). CONCLUSIONS:
Thrombocytopenia is associated with limitations on functional status and in-
creased health care utilization, some of which may be related to patients’ under-
lying health conditions. Further study is needed to determine the incremental
impact of thrombocytopenia.
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OBJECTIVES: Minimal health-related quality of life (HRQOL) data have been pub-
lished on myelodysplastic syndromes (MDS) patients in the United States. This
analysis characterized HRQOL by age group of MDS pts treated with Vidaza® in the
AVIDA® registry.METHODS: Data were collected from AVIDA, a Vidaza treatment
registry, initiated in US community clinics. Clinicians provided patient demo-
graphic, treatment pattern, and clinical outcome data. Patients reported HRQOL
(EORTC-QLQ-C30) within 2 months of treatment initiation. Mean (Standard Devia-
tion [SD]) scores on global health status (GHS), 5 functional scales and 9 symptom/
other scales were analyzed by age: 65, 65-74, 75 years. Statistical significance
was ascertained by ANOVA using SAS 9.1. RESULTS: Data were reported from 99
clinics on 427 pts:65 (n68), 65-74 (n127), and75 (n232) years.Mean (SD) GHS
was 54.8 (1.2) overall, and similar among age groups: 53.9 (2.9), 54.7 (2.1), and 55.2
(1.6), p0.9263. Similarly, physical, role, and social functioning were comparable.
Emotional and cognitive functioning, however, were worse among those 65 ver-
sus the older groups: 66.2 (3.5), 78.6 (1.8), 79.5 (1.5), p0.0001 for emotional, and 72.4
(3.5), 82.7 (1.7), 80.3 (1.4), p0.0067 for cognitive. The 65 cohort reported signifi-
cantly worse scores on 4 of 9 symptom/other scores: financial difficulties (34.8 (4.5),
15.3 (2.4), 13.0 (1.7), p0.0001); insomnia (39.7 (4.0), 27.5 (2.7), 27.3 (2.2), p0.0141);
appetite loss (29.9 (3.8), 18.4 (2.5), 25.3 (2.1), p0263); and fatigue 53.9 (3.1), 44.3 (2.3),
48.5 (1.8), p0.0452). CONCLUSIONS: AVIDA registry findings indicate baseline
HRQOL among MDS patients in real world settings differs by age in certain do-
mains. Findings suggest HRQOL is similar or better in elderly MDS patients than
younger patients. These differences in emotional and cognitive functioning, fa-
tigue, insomnia, appetite loss, and financial difficulties require consideration by
clinicians in managing MDS patients.
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OBJECTIVES: Chronic pain is a major public health concern in the US. Established
guidelines are available formanagement of non-malignant chronic pain, including
opioid use. However, discrepancies in opioid prescribing patterns due to physician
misconceptions remain concerning. Therefore, this study evaluated pain medica-
tion use and investigated determinants of opioid analgesic prescribing in the US
outpatient settings for common non-malignant chronic pain indications.
METHODS: This cross-sectional study analyzed the National Ambulatory Medical
Care Survey(NAMCS) data from 2002-2007 on patients 18 years and older with
non-malignant chronic pain diagnosis based on ICD-9-CM codes identified as rea-
son for visits. Painmedications prescribedwere retrieved usingNAMCSdrug codes.
Multivariate logistic models examined determinants of opioid prescribing among
chronic pain patients. RESULTS: Approximately 69 million weighted outpatient
visits were reported for non-malignant chronic pain between 2000-2007 in the US.
The mean age for patients was 53 (range 18-100) and the majority were
women(63%). Neuropathic pain was reported for 2.39% visits while 16.24% had an
inflammatory pain diagnosis. Non-medication treatment was prescribed during
26% of these visits. While most(95%) visits reported prescribing NSAIDs, 29% re-
ported receiving prescriptions for more than five medications. Primary care physi-
cians (PCPs) were 1.74 times more likely to prescribe opioids [OR(odds ratio):1.74,
CI:1.42-2.14] than other specialty physicians. Patients receiving more than five
medications were 2.80 times more likely to receive opioids (OR:2.80,CI:2.28-3.44)
than thosewith less thanfivemedications. Patients from the southern region of the
US were 1.43 times more likely to receive opioids (OR:1.43,CI:1.06-1.94) than pa-
tients from the northeast region. CONCLUSIONS: According to our study, visits
with PCPs, more than five prescriptions, established patients, and physician visits
in the southern region of the US were some of the determinants of opioid prescrib-
ing. Increased awareness of opioid prescription guidelines for pain management
may eliminate prescription discrepancies and improve patient care.
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OBJECTIVES: This study determined factors associated with treatment choice for
pain management in US nursing home hospice/palliative care residents.
METHODS: This is a cross sectional study of data from the resident file of the 2004
National Nursing Home Survey (NNHS). Residents assigned to a bed in a hospice
specialty unit or receiving services from a special program for hospice/palliative
care in 1174 systematically selected nursing homes and having pain in 7 days
before the surveywere included. Treatment choices included standing order (SO) of
analgesics, as-needed orders (PRN) of analgesics and non-pharmacological treat-
ment (NPT). Factors evaluated were gender, marital status, age, ethnicity, eating
limitation, toilet limitation, urinary incontinence and bowel incontinence.
Weighted descriptive analysis, bivariate analysis using chi-square tests and mul-
tivariate analysis using logistic regression were conducted using SAS version 9.2 to
determine factors associated with pain management. RESULTS: Overall 22.6%
(338,029/1,492,207,weighted) patients met the study inclusion criteria. Mean[SD]
age was 79.1[13.3] years, 74.7% were females and 89.8% were white. 78.6%, 49.8%,
and 29.3% received PRN, SO, and NPT, respectively. Logistic regression showed
higher likeliness to receive SO for patients of age at or above 65 years (OR1.51 95%
CI1.184-1.948 P0.001), patients with bowel incontinence (OR1.21 95%
CI1.020-1.437 P0.028) and Medicaid patients (OR1.5 95% CI1.258-1.799
P0.0001). Likeliness to receive PRN was lower for patients of age at or above 65
years (OR0.60 95% CI0.428-0.841 P0.0031), patients with bowel incontinence
(OR0.67 95%CI0.533-0.859 P0.0014), Medicaid patients (OR0.65 95%CI0.525-
0.806 P0.0001) and Hispanics (OR0.327 95% CI0.204-0.527 P0.001). Likeliness
to receive NPT was higher for patients with toileting limitation (OR2.905 95%
CI1.135-7.434 P0.026) and lower for patients with urinary incontinen-
ce(OR0.022 95% CI0.003-0.172 P0.0003). CONCLUSIONS: Factors affecting
treatment choice were age, bowel and urinary incontinence, toileting limitations,
ethnicity and insurance type and can be targeted in future studies aiming at man-
agement of pain in nursing homes.
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